首页> 美国卫生研究院文献>Case Reports in Neurology >Anti-Ganglioside Antibody-Negative Miller Fisher and AMSAN Variant Guillain-Barré Overlap Syndrome
【2h】

Anti-Ganglioside Antibody-Negative Miller Fisher and AMSAN Variant Guillain-Barré Overlap Syndrome

机译:抗神经节苷脂抗体阴性的Miller Fisher和AMSAN变异型Guillain-Barré重叠综合征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A case of Miller Fisher and acute motor sensory axonal neuropathy (AMSAN) variant Guillain-Barré (MFS/AMSAN-GBS) overlap syndrome is presented. The neurological presentation of the overlap syndrome was preceded by an upper respiratory tract infection. Eventually, severe weakness of bulbar and limb muscles, areflexia, ophthalmoplegia, ataxia, and respiratory insufficiency developed. The electroneuromyography revealed symmetrical axonal polyneuropathy which was dominant in both upper limbs. Although a panel of anti-ganglioside antibodies including anti-GQ1b was negative, immediate treatment with intravenous immunoglobulin resulted in dramatic response.
机译:介绍了一例Miller Fisher和急性运动感觉轴突神经病(AMSAN)变型格林-巴雷(MFS / AMSAN-GBS)重叠综合征。重叠综合征的神经系统表现是在上呼吸道感染之前。最终,发展出延髓和四肢肌肉的严重虚弱,反射力减退,眼肌麻痹,共济失调和呼吸功能不全。电镜检查显示对称的轴突性多发性神经病在两个上肢中均占主导。尽管包括抗GQ1b在内的一组抗神经节苷脂抗体均为阴性,但立即用静脉内免疫球蛋白治疗可引起剧烈反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号